Faron Pharma Share Price (FARN)

Dracula, I agree and something is missing and we all want to see it in SP.

Luk and Sax, One hell of a lot of work gone Into the Co In the last few years. Was It 30 ml finance arranged ?. Build up In the States ?. Nas?. Extra professional Staff employed on All fronts. Whats It All for ?. Surely All that Faron are working on Is showing some very good results ?. Seems the Only thing missing Is the SVV. IMO.

I guess these three are what you need to have as end results. Maybe now confidence to trust on biomarkers. Clever-1 expression is of course the “root cause” that explains their science and where Bex needs to bind to change the M2 phenotype in to M1 and so activates the immune system against cancer. After all we don’t know if it is intratumoral clever-1 or soluble clever-1 that finally breaks the back of the camel? Bex binds in both anyway. More simple way to go forward towards FDA?

Thanks Finngirl .
Also see that the Matins trial has had some tweaks as of 25th May .
The trial originally had 4 Primary Outcome Measures .
It now has only 3 .
The measure of Clever1 positivity in the tumour itself has been removed ..

So that leaves us with :
1.Toxicity issues with dosing
2.Adverse events
3.Objective response rate (ORR) - ie tumour size change

Quite what this means I don't know .

MLF is now listed as the main contact .

https://meetings.asco.org/abstracts-presentations/210232